reglab/housing_qa huggingface dataset:
Ohio Rev Code § 4729.12 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.12 | Licenses; Renewal.

Effective: September 29, 2017|Latest Legislation:  House Bill 49 - 132nd General Assembly|A license issued by the state board of pharmacy under section 4729.08 or 4729.11 of the Revised Code entitles the individual to whom it is issued to practice as a pharmacist or as a pharmacy intern in this state until the next renewal date.Licenses shall be renewed according to the standard renewal procedure of Chapter 4745. of the Revised Code and rules adopted by the board under section 4729.26 of the Revised Code. Licenses are valid for the period specified in the rules, unless earlier revoked or suspended by the board. The period shall not exceed twenty-four months unless the board extends the period in the rules to adjust license renewal schedules.A pharmacist or pharmacy intern who desires to continue in the practice of pharmacy shall file with the board an application in such form and containing such data as the board may require for renewal of a license. In the case of a pharmacist who dispenses or plans to dispense controlled substances in this state, the pharmacist shall certify, as part of the application, that the pharmacist has been granted access to the drug database established and maintained by the board pursuant to section 4729.75 of the Revised Code, unless the board has restricted the pharmacist from obtaining further information from the database or the board no longer maintains the database. If the pharmacist certifies to the board that the applicant has been granted access to the drug database and the board finds through an audit or other means that the pharmacist has not been granted access, the board may take action under section 4729.16 of the Revised Code.An application filed under this section for renewal of a license may not be withdrawn without the approval of the board.If the board finds that an applicant's license has not been revoked or placed under suspension and that the applicant has paid the renewal fee, has continued pharmacy education in accordance with the rules of the board, and is entitled to continue in the practice of pharmacy, the board shall renew the applicant's license.When a license has expired but an application is made within three years after the expiration of the license, the applicant's license shall be renewed without further examination if the applicant meets the requirements of this section and pays the fee designated under division (A)(5) of section 4729.15 of the Revised Code.A pharmacist or pharmacy intern who fails to renew the pharmacist's or intern's license by the renewal date prescribed by the board shall not engage in the practice of pharmacy until a valid license is issued by the board.
Ohio Rev Code § 4729.13 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.13 | Failure to Renew License.

Effective: September 29, 2017|Latest Legislation:  House Bill 49 - 132nd General Assembly|A pharmacist who fails to make application to the state board of pharmacy for a license renewal within a period of three years from the expiration of the license must pass an examination for licensure and comply with sections 4776.01 to 4776.04 of the Revised Code; except that a pharmacist whose license has expired, but who has continually practiced pharmacy in another state under a license issued by the authority of that state, may obtain a renewed license upon payment to the executive director of the board the fee designated under division (A)(6) of section 4729.15 of the Revised Code.
Ohio Rev Code § 4729.162 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.162 | Adoption of Rules Regarding Review of Patient Information Available Through Drug Database.

Effective: March 13, 2013|Latest Legislation:  Senate Bill 301 - 129th General Assembly|(A) As used in this section, "drug database" means the database established and maintained by the state board of pharmacy pursuant to section 4729.75 of the Revised Code. (B) The state board of pharmacy shall adopt rules in accordance with Chapter 119. of the Revised Code that establish standards and procedures to be followed by a pharmacist regarding the review of patient information available through the drug database under division (A)(6) of section 4729.80 of the Revised Code.(C) This section and the rules adopted under it do not apply if the board no longer maintains the drug database.
Ohio Rev Code § 4729.17 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.17 | Single Member May Hold Hearing.

Effective: August 30, 2007|Latest Legislation:  Senate Bill 58 - 127th General Assembly|Any investigation, inquiry, or hearing, which the state board of pharmacy is empowered to hold or undertake may be held or undertaken by or before any member or members of the board and the finding or order of such member or members shall be deemed to be the order of said board when approved and confirmed by a majority of the board members present and voting at a meeting of the board at which there is a quorum.
Ohio Rev Code § 4729.171 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.171 | Designation of Hearing Examiners.

Effective: April 6, 2017|Latest Legislation:  Senate Bill 319 - 131st General Assembly|(A)(1)(a) The state board of pharmacy may designate one or more attorneys at law who have been admitted to the practice of law, and who are classified as either administrative law attorney examiners or as administrative law attorney examiner administrators under the state job classification plan adopted under section 124.14 of the Revised Code, as hearing examiners, subject to Chapter 119. of the Revised Code, to conduct any hearing the board is empowered to hold or undertake pursuant to Chapter 119. of the Revised Code.(b) Notwithstanding the requirement of division (A)(1)(a) of this section that the board designate as a hearing examiner an attorney who is classified as either an administrative law attorney examiner or an administrative law attorney examiner administrator, the board may, subject to section 127.16 of the Revised Code, enter into a personal service contract with an attorney admitted to the practice of law in this state to serve as a hearing examiner.(2) The hearing examiner shall hear and consider the oral and documented evidence introduced by the parties and issue in writing proposed findings of fact and conclusions of law to the board for their consideration within thirty days following the close of the hearing.(B) The board shall be given copies of the transcript of the hearing record and all exhibits and documents presented by the parties at the hearing.(C) The board shall render a decision and take action within ninety days following the receipt of the hearing examiner's proposed findings of fact and conclusions of law.(D) The final decision of the board in any hearing shall be in writing and contain findings of fact and conclusions of law. Copies of the decision shall be delivered to the parties personally or by certified mail. The decision is final on delivery or mailing, but may be appealed as provided by Chapter 119. of the Revised Code.
Ohio Rev Code § 4729.19 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.19 | Cooperation in Investigation.

Effective: March 22, 2019|Latest Legislation:  Senate Bill 229 - 132nd General Assembly|Notwithstanding division (B)(4) of section 2317.02 of the Revised Code, a pharmacist, pharmacy intern, pharmacy technician trainee, registered pharmacy technician, certified pharmacy technician, terminal distributor of dangerous drugs, manufacturer of dangerous drugs, outsourcing facility, third-party logistics provider, repackager of dangerous drugs, or wholesale distributor of dangerous drugs shall cooperate with federal, state, and local government investigations and shall divulge all relevant information when requested by a government agency.
Ohio Rev Code § 4729.20 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.20 | Dispensing for Purposes of Medication Synchronization.

Effective: August 31, 2016|Latest Legislation:  House Bill 116 - 131st General Assembly|As used in this section, "medication synchronization" means a pharmacy service that synchronizes the filling or refilling of prescriptions in a manner that allows the dispensed drugs to be obtained on the same date each month. A pharmacist may dispense a drug in a manner that varies from the prescription for the drug by dispensing a quantity or amount of the drug that is less than a thirty-day supply, if the pharmacist's action is taken solely for the purpose of medication synchronization pursuant to section 1751.68, 3923.602, 5164.7511, or 5167.12 of the Revised Code.
Ohio Rev Code § 4729.23 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.23 | Confidential Information; Investigations and Inspections.

Effective: April 8, 2019|Latest Legislation:  House Bill 101 - 132nd General Assembly|(A) Except as provided in division (B) of this section, information received by the state board of pharmacy pursuant to an investigation is confidential, is not a public record, and is not subject to discovery in any civil action.  (B) The board shall conduct all investigations or inspections and proceedings in a manner that protects the confidentiality of patients, confidential informants, and individuals who file complaints with the board. The board shall not make public the names or any other identifying information of patients, confidential informants, or complainants unless proper consent is given or, in the case of a patient, a waiver of the patient privilege exists under division (B) of section 2317.02 of the Revised Code. The consent or waiver is not required if the board possesses reliable and substantial evidence that no bona fide physician-patient relationship exists. On request, the board may share any information it receives pursuant to an investigation or inspection, including patient records and patient record information, with law enforcement agencies, other licensing boards, and other state or federal governmental agencies that are prosecuting, adjudicating, or investigating alleged violations of statutes or administrative rules. An agency or board that receives the information shall comply with the same requirements regarding confidentiality as those with which the state board of pharmacy must comply, notwithstanding any conflicting provision of the Revised Code or agency procedure that applies when the agency is dealing with other information in its possession.Any information the board receives from a state or federal agency is subject to the same confidentiality requirements as the agency from which it was received and shall not be released by the board without prior authorization from that agency.The board may, for good cause shown, disclose or authorize disclosure of information gathered pursuant to an investigation. (C) Any board activity that involves continued monitoring of an individual for treatment or recovery purposes as part of or following any disciplinary action taken under this chapter shall be conducted in a manner that maintains an individual's confidentiality with respect to the individual's treatment or recovery program. Information received or maintained by the board with respect to the board's monitoring activities is not subject to discovery in any civil action, is not a public record, and is confidential, except that the board may disclose information to law enforcement officers and government entities for purposes of an investigation of a license or certificate holder.
Ohio Rev Code § 4729.24 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.24 | Authority of Board to Take Depositions, Issue Subpoenas, Etc.

Effective: September 29, 2017|Latest Legislation:  House Bill 49 - 132nd General Assembly|(A) Subject to division (B) of this section, in addition to the actions the state board of pharmacy may take under Chapter 119. of the Revised Code, the board may order the taking of depositions; examine and copy any books, accounts, papers, records, documents, and other tangible objects; issue subpoenas; and compel the attendance of witnesses and production of books, accounts, papers, records, documents, and other tangible objects.On failure of a person to comply with a subpoena issued by the board and after reasonable notice to that person, the board may apply to the court of common pleas of Franklin county for an order compelling the production of persons or records pursuant to the Ohio Rules of Civil Procedure.A subpoena issued by the board may be served by a sheriff, sheriff's deputy, or board employee designated by the board. Service of a subpoena may be made by delivering a copy of the subpoena to the person named in the subpoena or by leaving it at the person's usual place of residence.(B) A subpoena for patient record information may be issued only on approval by the board's executive director and the president or another board member designated by the president, in consultation with the office of the attorney general. Before issuing the subpoena, the executive director and the office of the attorney general shall determine whether probable cause exists to believe that the complaint filed alleges, or an investigation has revealed, a violation of this chapter or Chapters 2925., 3715., 3719., or 3796. of the Revised Code or any rule adopted by the board, that the records sought are relevant to the alleged violation and material to the investigation, and that the records cover a reasonable period of time surrounding the alleged violation.(C) The board may adopt rules in accordance with Chapter 119. of the Revised Code establishing procedures to be followed in taking the actions authorized by this section, including procedures regarding payment for and service of subpoenas.
Ohio Rev Code § 4729.25 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.25 | Enforcement.

Effective: May 18, 2005|Latest Legislation:  House Bill 377 - 125th General Assembly|(A) The state board of pharmacy shall enforce, or cause to be enforced, this chapter. If it has information that any provision of this chapter has been violated, it shall investigate the matter, and take such action as it considers appropriate.(B) Nothing in this chapter shall be construed to require the state board of pharmacy to enforce minor violations of this chapter if the board determines that the public interest is adequately served by a notice or warning to the alleged offender.
Ohio Rev Code § 4729.26 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.26 | Administrative Rules.

Effective: May 18, 2005|Latest Legislation:  House Bill 377 - 125th General Assembly|The state board of pharmacy may adopt rules in accordance with Chapter 119. of the Revised Code, not inconsistent with the law, as may be necessary to carry out the purposes of and to enforce the provisions of this chapter. The rules shall be published and made available by the board to each pharmacist licensed under this chapter.
Ohio Rev Code § 4729.27 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.27 | Pharmacist Must Be in Full and Actual Charge of Pharmacy.

Effective: July 22, 1998|Latest Legislation:  Senate Bill 66 - 122nd General Assembly|A person not a pharmacist, who owns, manages, or conducts a pharmacy, shall employ a pharmacist to be in full and actual charge of such pharmacy. Any pharmacist who owns, manages, or conducts a pharmacy shall be personally in full and actual charge of the pharmacy, or shall employ another pharmacist to be in full and actual charge of the pharmacy.
Ohio Rev Code § 4729.28 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.28 | Unauthorized Practice.

Effective: April 8, 2019|Latest Legislation:  House Bill 101 - 132nd General Assembly|(A) As used in this section, "dispense" has the meaning specified by the state board of pharmacy in rules adopted under section 4729.26 of the Revised Code. (B)(1) Except as provided in division (B)(2) of this section, no person who is not a pharmacist or a pharmacy intern under the personal supervision of a pharmacist shall compound or sell dangerous drugs or otherwise engage in the practice of pharmacy. (2) Except as provided in sections 3701.048, 4729.44, and 4729.47 of the Revised Code or rules adopted by the board under section 4729.26 of the Revised Code, no person who is not a pharmacist shall dispense dangerous drugs.
Ohio Rev Code § 4729.282 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.282 | Dispensing of Drugs Pursuant to Prescriptions Made Without Examination and Ept Prescriptions.

Effective: March 23, 2016|Latest Legislation:  House Bill 124 - 131st General Assembly|(A) Notwithstanding any conflicting provision of this chapter or rule adopted by the state board of pharmacy, a pharmacist may do both of the following with respect to a prescription issued under section 4723.4810, 4730.432, or 4731.93 of the Revised Code: (1) Dispense a drug pursuant to the prescription ; (2) Label a drug dispensed pursuant to the prescription without the name of the individual for whom the drug is intended if the prescription contains the words "expedited partner therapy" or the letters "EPT." (B) For each drug dispensed under this section, the pharmacist shall provide all of the following information: (1) Directions for use of the drug; (2) Any side effects, adverse reactions, or known contraindications associated with the drug. (C) A pharmacist who in good faith dispenses a drug under this section is not liable for or subject to any of the following: (1) Damages in any civil action; (2) Prosecution in any criminal proceeding; (3) Professional disciplinary action. (D) This section does not affect the authority of a pharmacist to distribute information concerning a drug as required by federal law.
Ohio Rev Code § 4729.283 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.283 | Dispensing Naltrexone Without Prescription.

Effective: March 20, 2019|Latest Legislation:  Senate Bill 119 - 132nd General Assembly|(A) A pharmacist may dispense naltrexone without a written or oral prescription from a licensed health professional authorized to prescribe drugs if all of the following conditions are met: (1) The pharmacist is able to verify a record of a prescription for the injectable long-acting or extended-release form of naltrexone in the name of the patient who is requesting the drug, but the prescription does not provide for a refill or the time permitted by rules adopted by the state board of pharmacy for providing refills has elapsed. (2) The pharmacist is unable to obtain authorization to refill the prescription from the prescriber who issued it or another prescriber responsible for the patient's care. (3) In the exercise of the pharmacist's professional judgment: (a) The drug is necessary to continue the patient's therapy for substance use disorder. (b) Failure to dispense the drug to the patient could result in harm to the health of the patient. (B) Before dispensing naltrexone under this section, the pharmacist shall offer the patient the choice of receiving either the oral form or injectable long-acting or extended- release form, but only if both forms of the drug are available for dispensing at the time of the patient's request or within one day after the request. (C)(1) With respect to naltrexone dispensed in an oral form under this section, the pharmacist shall not dispense an amount that exceeds a five-day supply. (2) With respect to naltrexone dispensed in an injectable long-acting or extended-release form under this section, both of the following apply: (a) The pharmacist shall exercise professional judgment in determining the amount of the drug dispensed. (b) The pharmacist may administer the drug by injection to the patient but only in accordance with section 4729.45 of the Revised Code. (D) A pharmacist who dispenses naltrexone under this section shall do all of the following: (1) For one year after the date of dispensing, maintain a record in accordance with this chapter of the drug dispensed, including the amount and form dispensed, the original prescription number, the name and address of the patient and, if the individual receiving the drug is not the patient, the name and address of that individual; (2) Notify the prescriber who issued the prescription described in division (A)(1) of this section or another prescriber responsible for the patient's care not later than five days after the drug is dispensed; (3) If applicable, obtain authorization for additional dispensing from one of the prescribers described in division (D) (2) of this section. (E) A pharmacist shall exercise professional judgment in determining the number of times naltrexone may be dispensed under this section to the same patient. (F) This section does not limit the authority of a pharmacist to dispense a dangerous drug under section 4729.281 of the Revised Code.
Ohio Rev Code § 4729.285 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.285 | Telehealth Services.

Effective: March 23, 2022|Latest Legislation:  House Bill 122 - 134th General Assembly|A pharmacist may provide telehealth services in accordance with section 4743.09 of the Revised Code, except that in the case of dispensing a dangerous drug, a pharmacist shall not use telehealth mechanisms or other virtual means to perform any of the actions involved in dispensing the dangerous drug unless the action is authorized by the state board of pharmacy through rules it adopts under this chapter or section 4743.09 of the Revised Code. Last updated January 27, 2022 at 3:20 PM
Ohio Rev Code § 4729.29 (2021)
2021 Ohio Revised Code|Title 47 | Occupations-Professions|Chapter 4729 | Pharmacists; Dangerous Drugs|Section 4729.29 | Exemptions.

Effective: December 16, 2020|Latest Legislation:  House Bill 341 - 133rd General Assembly|Divisions (A) and (B) of section 4729.01 and section 4729.28 of the Revised Code do not do any of the following: (A) Apply to a licensed health professional authorized to prescribe drugs who is acting within the prescriber's scope of professional practice; (B) Prevent a prescriber from personally furnishing the prescriber's patients with drugs, within the prescriber's scope of professional practice, that seem proper to the prescriber, as long as the drugs are furnished in accordance with section 4729.291 of the Revised Code; (C) Apply to an individual who personally furnishes a supply of naloxone under authority conferred under section 4723.485, 4730.435, or 4731.941 of the Revised Code or prevent that individual from personally furnishing the supply of naloxone in accordance with a protocol established under section 4723.485, 4730.435, or 4731.941 of the Revised Code; (D) Apply to the sale of oxygen, the sale of peritoneal dialysis solutions, or the sale of drugs that are not dangerous drugs by a retail dealer, in original packages when labeled as required by the "Federal Food, Drug, and Cosmetic Act," 52 Stat. 1040 (1938), 21 U.S.C.A. 301, as amended.